Discussion  by unknown
Cardiology Committee for Practice Guidelines and Policy Conferences
(Committee to Develop Guidelines for the Management of Patients
With Atrial Fibrillation) Developed in Collaboration With the North
American Society of Pacing and Electrophysiology. Circulation.
2001;104:2118-50.
4. Cox JL, Schuessler RB, D’Agostino HJ Jr, et al. The surgical treatment
of atrial fibrillation: III. Development of a definitive surgical procedure.
J Thorac Cardiovasc Surg. 1991;101:569-83.
5. Melo JQ, Adraga˜o P, Neves J, et al. Surgery for atrial fibrillation using
intra-operative radiofrequency ablation. Rev Port Cardiol. 1998;17:
377-9.
6. KnautM, Spitzer SG, Karolyi L, et al. Intraoperative microwave ablation
for curative treatment of atrial fibrillation in open heart surgery—the
MICRO_STAF and MICRO_PASS pilot trial. Thorac Cardiovasc
Surg. 1999;47:379-84.
7. Sie HT, Beukema WP, Ramdat Misier AR, Elvan A, Ennema JJ,
Wellens HJJ. The radiofrequency modified maze procedure. A less inva-
sive surgical approach to atrial fibrillation during open-heart surgery.
Eur J Cardiothorac Surg. 2001;19:443-7.
8. Lee JW, Choo SJ, Kim KI, et al. Atrial fibrillation surgery simplified
with cryoablation to improve left atrial function. Ann Thorac Surg.
2001;72:1479-83.
9. Melo J, Adragao P, Neves J, et al. Endocardial and epicardial radiofre-
quency ablation in the treatment of atrial fibrillation with a new intra-
operative device. Eur J Cardiothorac Surg. 2000;18:182-6.
10. Lima GG, Kalil RA, Leiria TL, et al. Randomized study of surgery for
patients with permanent atrial fibrillation as a result of mitral valve dis-
ease. Ann Thorac Surg. 2004;77:2089-94.
11. Jessurun ER, van Hemel NM, Defauw JJ, et al. A randomized study of
combining. The maze surgery for atrial fibrillation with mitral valve
surgery. J Cardiovasc Surg. 2003;44:9-18.
12. Akpinar B, Guden M, Sagbas E, Sanisoglu I, Ozbek U, et al. Combined
radiofrequencymodified maze andmitral valve procedure through a port
access approach: early and mid-term results. Eur J Cardiothorac Surg.
2003;24:223-30.
13. Prasad SM, Maniar HS, Camillo CJ, et al. The Cox maze III procedure
for atrial fibrillation: long-term efficacy in patients undergoing lone ver-
sus concomitant procedures. J Thorac Cardiovasc Surg. 2003;126:
1822-8.
14. Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the
methods, efficacy, and safety of catheter ablation for human atrial fibril-
lation. Circulation. 2005;111:1100-5.
Discussion
Dr Ralph J. Damiano (St Louis, Mo). I would like to congratulate
DrMelo for initiating this international registry and his coauthors for
participating in this noble endeavor. As time progresses, I have no
doubt it will yield very useful information and provide a broad
look at current surgical practice for the treatment of atrial fibrillation.
Already Dr Melo and his colleagues have assembled the largest re-
ported series of concomitant mitral and atrial fibrillation surgery.
Although the registry does represent a major contribution to the
field, it suffers from the shortcomings of all voluntary retrospective da-
tabases, and these shortcomings include selection and reporting bias
and significant inhomogeneity of the patient populations, surgical
skill, and technique anddiffering follow-up regimensbetween centers.
In my opinion the most significant finding of this study is that
sSR was associated with better early and late survival and fewer
thromboembolic events during the follow-up period. This has con-
firmed the work of Bando and others and adds further testimony
to the crucial importance of performing atrial fibrillation surgery
in patients who have chronic atrial fibrillation and are referred for
the treatment of valvular heart disease.
Dr Melo, I have a number of questions for you. First, was there
any attempt to standardize the follow-up between centers? For a
patient to be considered to be either in sSR or sAF, were electrocar-
diographic or Holter monitoring data required to document the
actual rhythm? If a patient had atrial flutter 6 months postoperatively
and required an interventional procedure to terminate the flutter but
then was in sinus rhythm at 1 year, would you consider that a failure
or a success?
Dr Melo. Of course, this is a retrospective database, and there-
fore there was not the possibility of standardizing follow-up, but
I should comment that if we have these activities to survive, we
have to be more scientific. Therefore we need further time in putting
together data prospectively instead of just to survive and to undoubt-
edly prove the things for which we are looking.
Regarding the information based on 12-lead electrocardiography
or surface electrocardiography, which, of course, has the drawbacks
of which we are all aware, at least there was an electrocardiogram to
support that information.
Regarding patients who need to be cardioverted within the first
semester and then remain in sinus rhythm, those patients would be
classified as in sSR.
Dr Damiano.How about if they required an interventional cath-
eterization to ablate atrial flutter, was that considered a success also
if they went into sSR?
Dr Melo. That patient would be censored for this study because
we have 2 or 3 patients. That patient represents a failure of surgical
intervention, and therefore he needs to go to the catheterization lab-
oratory for our goal of being very strict because, as you know, most
reports, including Dr Bando’s, are not talking about sinus rhythm.
He is talking about regular rhythms, and most reports are talking
about atrial fibrillation, which is a rather different issue.
Dr Damiano. My second question is that you had a wide range
of ablation technologies in your study. Did you notice that ablation
energy source had any effect on late results?
DrMelo. That is the $1 million question. We have to realize that
unipolar radiofrequency, as you know, is less and less used, as op-
posed to actual analysis from bipolar and argon cryoablation, which
are the energies that are currently being used. As you know, we had
4% and 5%. Therefore we did not make comparisons between dif-
ferent forms of ablation energy, but compared instead cut-and-sew
technique with ablation. We did not show any improved results us-
ing the cut-and-sew technique, even though we might have the
shortcoming of having only 44 patients with the cut-and-sew tech-
nique, which is at this point maybe more critical to understand
why most reports with the cut-and-sew techniques, which are
maze techniques, apparently have slightly better results.
Dr Damiano. In a study that we published in 2005 on predictors
of late recurrence after a full maze procedure, we found that the du-
ration of preoperative atrial fibrillation was the strongest predictor of
arrhythmia occurrence and operative failure. Did you find this to be
a predictor of sSR in your database?
DrMelo.No, and we looked thoroughly at that, and this is pretty
much coincident with several articles published individually by
several groups. It was not.
Dr Damiano. Finally, I was wondering whether you can explain
the relatively poor late results of patients in your registry? The 1-
year freedom from atrial fibrillation was only 66%, and if I have cal-
culated from your manuscript correctly, the drug-free sSR rate at 1
year was only 44%. This compares to certainly our own historical
rate, where we have sSRs of more than 95% at 10 years, and 75%
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of those patients are drug free and in sinus rhythm, either a normal
sinus rhythm or a paced rhythm. Even with ablation devices, we are
presently getting more than 90% sSR at 1 year, and approximately
70% of patients are drug free. Do you believe that the worse results
in this registry are due to the fact that 65% of patients only under-
went left-sided procedures and you found that that was perhaps
a risk factor for worse results? Also, of the left-sided procedures,
three quarters of those patients only had pulmonary vein isolation,
which many investigators, including myself, would believe would
be an inadequate operation for patients with large left atria and
organic heart disease?
DrMelo. I think this is a very good question. I am not sure about
the answer, even though from your question you are implying the
answer. Number one, this is a pretty unselected patient population;
left atrial size is, on average, 57 mm. Therefore those are very sick
patients, at least a large number of patients, which might have af-
fected these results. On the other hand, I do concur with you and
it is currently my practice that we should be performing biatrial ap-
proaches now on the basis of these data, and those are on the basis of
our knowledge from the maze operation.
But more important than that, I think that you can dump, as you
promised, your data in our database to compare apples with apples,
which I am not sure we have been doing historically.
Dr Kevin D. Accola (Orlando, Fla). I congratulate the authors
for putting together such a nice registry because it certainly helps
clarify, with the array of energy sources, the results of this new tech-
nology. My question to you is about the cohort of patients who have
had a pacemaker; you listed that you did have some, but you really
did not elucidate that group of patients. Did this group of patients do
better going from a chronic atrial fibrillation state to a paced atrial
ventricular synchronous state? I would be interested in this because
we are still experiencing, in some studies and in our practice, a 12%
to 14% incidence of pacemaker insertion. Therefore I would be in-
terested if you looked at this cohort individually and if these patients
did better.
DrMelo.We did look at that, and we have an incidence of pace-
makers after left-sided approaches of 2%, and we have an incidence
of biatrial approaches, mazes plus whatever lines you do on the right
side, at 1 year of 10%. And those patients, if they had a sequential
pacemaker, they were considered in sSR, but if they had only
PVI, they would be atrial fibrillation patients. But I cannot give
you in detail what has happened to that particular group of patients
besides what I told you.
Dr Accola. As a follow-up, do you anticoagulate these patients
for a particular duration, or what is your guidance to us on that?
Dr Melo. I think there is no evidence at the moment from what-
ever source that it is safe to interrupt anticoagulation on these pa-
tients, even if you close the left atrial appendage. Besides, you
have very strongmedical evidence that it is dangerous to stop antico-
agulants because in patients undergoing mitral surgery, who are
mostly rheumatic, there is very good evidence. The oldest one I
am aware of is coming from theMayoClinic showing that of thrombi
in lone atrial fibrillation, more than 90% start in the left atrial append-
age, but in the context of rheumatic fever, half of thrombi are in the
body of the left atriumbecause of the degenerative disease. Therefore
I think that in most patients, especially if they are rheumatic, I do not
believe it is safe to interrupt anticoagulants at this point.
Dr Guo-Wei He (Hong Kong, China). I congratulate you, Dr
Melo, on your excellent presentation. My question is actually just
to touch on your response to the previous discussant. My question
is related to rheumatic heart disease. As you know, I am from China.
We have a big problem with rheumatic heart disease. Most patients
with mitral valve disease have a cause of rheumatic disease. There-
fore I would like to know what is the incidence of rheumatic heart
disease in this group? Furthermore, and more importantly, are there
any differences among those patients with rheumatic heart disease
after mitral surgery and with atrial fibrillation surgery who remain
in sinus rhythm 1 year later compared with those who did not
have atrial fibrillation surgery regarding the rate of sinus rhythm 1
or 2 years later in patients who had mitral surgery with rheumatic
heart disease, the other group of that cause?
Dr Melo. As to the cause of disease of these patients, as I
showed, around 60% had rheumatic fever. As far as it concerns these
patients, if you are dealing with patients with very enlarged atria,
very diseased atria, sometimes they do not even have myocytes,
and I think it is not worthwhile to perform atrial fibrillation, espe-
cially because on those patients your success rate at 1 year, as we
have reported 10 years ago, is in the range of 15%. And now we
know by this kind of analysis that it is eventually worse for a patient
to be on an intermittent route than to be in atrial fibrillation. The
worst scenario for those patients is the 4% or 5% of patients who,
after these extensive procedures, instead of having a fibrillating
atrium have a steady atrium, and I believe this is worse for thrombi.
We still are treating patients with rheumatic fever. In those patients,
if they have a large left atrium, we do not perform the operation.
I think it is not worthwhile.
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